Clinic
Michigan Urgent Care
Michigan Urgent Care was paid $3.24M by Medicaid between Jan 2018 and May 2021, across 64 billing codes. Its largest line is 99204, doctor's office visit, new patient (more involved) — 35% of everything it billed.
33Billing provider infoMICHIGAN URGENT CARE
WYANDOTTE, MI 48192
WYANDOTTE, MI 48192
33aNPI1982060935assigned 01/06/2016
33bProvider typeUrgent Care Clinic/Center
28Total paid$3.24M
24GClaims93,346
24DCodes billed64
24AFirst – last monthJan 2018 – May 2021
Compared with peers
Next to other Urgent Care Clinic/Center providers in Michigan
Rank by total paid#24 of 239
Median peer was paid$346K
This provider vs. median9.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 24,414 | $835K | |
| 2019 | 31,070 | $1.11M | |
| 2020 | 32,287 | $1.02M | |
| 2021 | 5,575 | $272K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 35% | 13,223 | 13,109 | $1.12M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 29% | 15,610 | 14,695 | $939K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 18% | 9,255 | 9,215 | $577K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.6% | 6,635 | 6,394 | $310K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.0% | 5,807 | 5,702 | $64K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.7% | 2,712 | 2,629 | $56K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,161 | 4,021 | $31K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 400 | 399 | $20K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 572 | 553 | $19K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 175 | 175 | $13K |
| 81025 | <1% | 1,940 | 1,909 | $11K | |
| 81003 | <1% | 6,625 | 6,420 | $10K |
52 more codes
| 71046 | Radiologic examination, chest; 2 views | <1% | 615 | $8K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 880 | $7K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 173 | $7K |
| 73610 | <1% | 352 | $5K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,685 | $5K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 956 | $5K |
| 73130 | <1% | 295 | $4K | |
| 99205 | Prolong outpt/office vis | <1% | 39 | $4K |
| 73630 | <1% | 286 | $4K | |
| 99051 | <1% | 8,327 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,844 | $3K |
| 90714 | <1% | 116 | $2K | |
| 73110 | <1% | 86 | $1K | |
| 93000 | <1% | 190 | $1K | |
| 73562 | <1% | 97 | $1K | |
| 99000 | <1% | 3,571 | $933.59 | |
| 10060 | <1% | 14 | $875.73 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 119 | $767.45 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 960 | $647.90 |
| 12001 | <1% | 13 | $562.21 | |
| 94200 | <1% | 50 | $419.55 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 568 | $395.94 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 15 | $394.56 |
| 73030 | <1% | 27 | $347.22 | |
| 74018 | <1% | 27 | $329.25 | |
| 81002 | <1% | 90 | $229.54 | |
| 82962 | <1% | 84 | $145.53 | |
| 86308 | <1% | 14 | $57.24 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 22 | $53.20 |
| A6449 | Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard | <1% | 367 | $34.88 |
| 94760 | <1% | 1,834 | $24.16 | |
| Q4049 | Finger splint, static | <1% | 14 | $12.40 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 43 | $10.06 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 390 | $1.04 |
| G9350 | Ct scan of the paranasal sinuses not ordered at the time of diagnosis or received within 28 days after date of diagnosis | 0% | 19 | $0.00 |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | 0% | 32 | $0.00 |
| 94761 | 0% | 72 | $0.00 | |
| 1036F | 0% | 119 | $0.00 | |
| G9286 | Antibiotic regimen prescribed within 10 days after onset of symptoms | 0% | 23 | $0.00 |
| G8708 | Patient not prescribed antibiotic | 0% | 32 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 96 | $0.00 |
| G9364 | Sinusitis caused by, or presumed to be caused by, bacterial infection | 0% | 25 | $0.00 |
| 99173 | 0% | 489 | $0.00 | |
| J7510 | Prednisolone oral, per 5 mg | 0% | 247 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 393 | $0.00 |
| G9498 | Antibiotic regimen prescribed | 0% | 23 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 0% | 239 | $0.00 |
| 3210F | 0% | 21 | $0.00 | |
| G8731 | Pain assessment using a standardized tool is documented as negative, no follow-up plan required | 0% | 90 | $0.00 |
| 4004F | 0% | 17 | $0.00 | |
| A4565 | Slings | 0% | 13 | $0.00 |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 0% | 118 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialARSIWALA, MUSTAFA (CFO)